About
AVITA Medical is a regenerative medicine company based in Valencia, California, specializing in advanced wound care and skin restoration technologies. Originally founded as Clinical Cell Culture, the company rebranded in 2008 and is publicly traded on the Australian Securities Exchange and the U.S. OTC market. The company’s flagship product, the RECELL® System, is an FDA-approved device that utilizes a small sample of the patient’s skin to prepare Spray-On Skin™ cells, promoting rapid healing for thermal burns and skin defects. AVITA also offers ReNovaCell for aesthetic applications, ReGenerCell for chronic wounds, and holds exclusive U.S. rights to PermeaDerm®, a biosynthetic wound matrix. Additionally, Cohealyx™, a collagen-based dermal matrix, is marketed exclusively in the U.S. AVITA Medical serves a global market, focusing on hospitals, burn centers, and wound care specialists. The company is dedicated to improving patient outcomes through innovative solutions and extensive clinical research, emphasizing quality and integrity in its operations.
Technologies
Keywords
Company Information
-
Employees 260
-
Founded 2008
-
Annual Revenue $64251000
-
Total Funding $126680550
Location
28159 Avenue Stanford, Santa Clarita, California, United States, 91355-1106